Jong Liu, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 5454 S Hohman Ave, Hammond, IN 46320 Phone: 219-933-2006 Fax: 219-738-6714 |
Jong-il Marcus Lee, MD Radiology - Nuclear Radiology Medicare: Not Enrolled in Medicare Practice Location: 5454 Hohman Ave, Hammond, IN 46320 Phone: 219-933-2006 Fax: 219-738-6714 |
Peter J Georgis, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 5454 Hohman Ave, Hammond, IN 46320 Phone: 219-933-2006 Fax: 219-738-6714 |
Kannan Kandallu, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 5454 Hohman Ave, Hammond, IN 46320 Phone: 219-933-2006 Fax: 219-738-6714 |
Do Ji Paik, MD Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 5454 Hohman Ave, Hammond, IN 46320 Phone: 219-933-2006 Fax: 219-738-6714 |
Dr. Urmi Pradeep Kalokhe, MD Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 5454 Hohman Ave, Hammond, IN 46320 Phone: 219-933-2130 Fax: 219-933-2634 |
Himanshu Y Doshi, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 5454 Hohman Ave, Hammond, IN 46320 Phone: 219-933-2006 Fax: 219-738-6714 |
News Archive
A London NHS trust would challenge proposals to end child heart surgery at the Royal Brompton Hospital. The Royal Brompton and Harefield NHS Foundation Trust added that this would mean the loss of other services, which could call into question its viability.
The development of prediction models that included variables such as pretreatment sexual function, patient characteristics and treatment factors appear to be effective at predicting erectile function 2 years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer, according to a study in the September 21 issue of JAMA.
A study in The Journal of Cell Biology shows how a transcription factor called STAT3 remains in the axon of nerve cells to help prevent neurodegeneration. The findings could pave the way for future drug therapies to slow nerve damage in patients with neurodegenerative diseases.
Omeros Corporation today announced positive data in the most commonly used model for studying the clinical and pathological features of multiple sclerosis (MS), further advancing its development program of GPR17-targeting compounds for the treatment of MS. Compounds previously discovered by Omeros that inhibit GPR17, an orphan G protein-coupled receptor (GPCR) unlocked by Omeros, significantly improved function from experimental autoimmune encephalomyelitis (EAE) in mice.
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
› Verified 3 days ago